It is well known that healthy people have cells with oncogenic K-Ras in different organs at rates far exceeding the rates of cancer development, and Magliano and Lonsdon (2013) report that the presence of oncogenic KRAS is not sufficient to transform cells, but the mechanism that removes barriers to tumorigenesis, is unknown48. This evidence concerns the gene KRAS and cancer.